MetLife Current Deferred Revenue vs Good Will Analysis
MET Stock | USD 70.42 1.48 2.06% |
MetLife financial indicator trend analysis is infinitely more than just investigating MetLife recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MetLife is a good investment. Please check the relationship between MetLife Current Deferred Revenue and its Good Will accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.
Current Deferred Revenue vs Good Will
Current Deferred Revenue vs Good Will Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MetLife Current Deferred Revenue account and Good Will. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between MetLife's Current Deferred Revenue and Good Will is -0.06. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Good Will in the same time period over historical financial statements of MetLife, assuming nothing else is changed. The correlation between historical values of MetLife's Current Deferred Revenue and Good Will is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of MetLife are associated (or correlated) with its Good Will. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Good Will has no effect on the direction of Current Deferred Revenue i.e., MetLife's Current Deferred Revenue and Good Will go up and down completely randomly.
Correlation Coefficient | -0.06 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Good Will
An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.Most indicators from MetLife's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MetLife current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.At this time, MetLife's Enterprise Value Over EBITDA is comparatively stable compared to the past year. Enterprise Value Multiple is likely to gain to 21.48 in 2024, whereas Selling General Administrative is likely to drop slightly above 5.8 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 71.1B | 69.9B | 66.4B | 52.8B | Total Revenue | 71.1B | 69.9B | 66.4B | 52.8B |
MetLife fundamental ratios Correlations
Click cells to compare fundamentals
MetLife Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MetLife fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 944.4M | 913.2M | 869.4M | 808.9M | 762.3M | 954.7M | |
Total Assets | 740.5B | 795.1B | 759.7B | 666.6B | 687.6B | 656.2B | |
Short Long Term Debt Total | 16.9B | 18.1B | 17.4B | 18.0B | 18.8B | 18.1B | |
Other Current Liab | (235M) | (393M) | (341M) | (2.8B) | 190M | 180.5M | |
Total Current Liabilities | 235M | 393M | 341M | 217M | 309M | 293.6M | |
Total Stockholder Equity | 66.1B | 74.6B | 67.5B | 27.0B | 30.0B | 46.4B | |
Net Debt | 253M | (1.6B) | (2.6B) | (2.2B) | (1.8B) | (1.7B) | |
Retained Earnings | 33.1B | 36.5B | 41.2B | 42.0B | 40.1B | 24.7B | |
Cash | 16.6B | 19.8B | 20.0B | 20.2B | 20.6B | 12.6B | |
Other Assets | 8.6B | 6.1B | (10.1B) | 357.5B | 373.7B | 392.4B | |
Cash And Short Term Investments | 348.3B | 378.5B | 367.5B | 301.9B | 308.1B | 188.5B | |
Liabilities And Stockholders Equity | 740.5B | 795.1B | 759.7B | 666.6B | 687.6B | 656.2B | |
Non Current Liabilities Total | 25.7B | 28.8B | 26.8B | 639.1B | 657.0B | 689.9B | |
Other Stockholder Equity | 20.0B | 20.0B | 15.4B | 12.2B | 9.1B | 8.6B | |
Total Liab | 674.1B | 720.3B | 692.0B | 639.3B | 657.3B | 609.5B | |
Total Current Assets | 368.7B | 396.4B | 384.8B | 297.0B | 302.1B | 286.7B | |
Accumulated Other Comprehensive Income | 13.1B | 18.1B | 10.9B | (27.1B) | (19.2B) | (18.3B) | |
Short Term Debt | 268M | 235M | 393M | 341M | 119M | 113.1M | |
Other Liab | 548.5B | 663.5B | 633.0B | 512.5B | 589.3B | 618.8B | |
Accounts Payable | 363M | 129M | 2.2B | 20.8B | 18.7B | 19.7B | |
Non Current Assets Total | 363.1B | 392.7B | 385.0B | 12.1B | 11.8B | 11.3B | |
Non Currrent Assets Other | (363.1B) | (392.7B) | (385.0B) | (309.3B) | (164.7B) | (173.0B) | |
Long Term Debt | 4.1B | 4.0B | 17.1B | 17.8B | 18.7B | 13.0B | |
Net Receivables | 20.4B | 17.9B | 17.3B | 17.5B | 29.2B | 18.7B | |
Good Will | 9.3B | 10.1B | 9.5B | 9.3B | 9.2B | 7.7B | |
Short Term Investments | 331.7B | 358.7B | 347.5B | 281.7B | 287.5B | 190.6B | |
Inventory | (62.4B) | (59.9B) | (55.4B) | (104.3B) | (93.9B) | (89.2B) | |
Treasury Stock | (12.7B) | (13.8B) | (18.2B) | (21.5B) | (19.3B) | (18.3B) | |
Intangible Assets | 19.1B | 18.7B | 18.3B | 25.5B | 20.9B | 12.2B | |
Property Plant Equipment | 2.8B | 2.6B | 2.2B | 1.9B | 2.1B | 1.5B | |
Property Plant And Equipment Net | 354.0B | 381.7B | 375.3B | 1.9B | (148.6B) | (141.2B) | |
Other Current Assets | 62.4B | 59.9B | 55.4B | (22.4B) | 69.1B | 97.5B | |
Noncontrolling Interest In Consolidated Entity | 238M | 259M | 267M | 247M | 284.1M | 303.9M | |
Retained Earnings Total Equity | 33.1B | 36.5B | 41.2B | 42.0B | 48.2B | 30.2B | |
Deferred Long Term Liab | 9.1B | 11.0B | 9.7B | 325M | 373.8M | 355.1M | |
Net Tangible Assets | 56.8B | 64.4B | 57.9B | 17.7B | 16.0B | 15.2B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.Note that the MetLife information on this page should be used as a complementary analysis to other MetLife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for MetLife Stock analysis
When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is MetLife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetLife. If investors know MetLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetLife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Dividend Share 2.06 | Earnings Share 1.81 | Revenue Per Share 88.295 | Quarterly Revenue Growth 0.219 |
The market value of MetLife is measured differently than its book value, which is the value of MetLife that is recorded on the company's balance sheet. Investors also form their own opinion of MetLife's value that differs from its market value or its book value, called intrinsic value, which is MetLife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetLife's market value can be influenced by many factors that don't directly affect MetLife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetLife's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetLife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetLife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.